Brent Sabatini

CIK: 0002037272

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (77.8%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (22.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

VIR

Vir Biotechnology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

VIR
Vir Biotechnology, Inc.
Jun 1, 2026
Sale(S)
Direct
379 shares at avg. $9.45$4K
VIR
Vir Biotechnology, Inc.
Mar 23, 2026
Sale(S)
Direct
7.7K shares at avg. $9.12$70K
VIR
Vir Biotechnology, Inc.
Feb 24, 2026
Sale(S)
Direct
1.4K shares at avg. $9.53$14K
VIR
Vir Biotechnology, Inc.
Feb 23, 2026
Sale(S)
Direct
1.8K shares at avg. $7.45$14K
VIR
Vir Biotechnology, Inc.
Feb 22, 2026
Award(A)
Direct
25K shares-
VIR
Vir Biotechnology, Inc.
Feb 13, 2026
Sale(S)
Direct
1.5K shares at avg. $7.79$12K
VIR
Vir Biotechnology, Inc.
Feb 24, 2025
Sale(S)
Direct
1.6K shares at avg. $9.45$15K
VIR
Vir Biotechnology, Inc.
Feb 22, 2025
Award(A)
Direct
20K shares-
VIR
Vir Biotechnology, Inc.
Feb 13, 2025
Sale(S)
Direct
1.6K shares at avg. $9.15$14K

		Type	Shares	Price		Ownership
Jun 1, 2026	VIR Vir Biotechnology, Inc.	Sale(S)	379	$9.45	$3,582	Direct
Mar 23, 2026	VIR Vir Biotechnology, Inc.	Sale(S)	7,711	$9.12	$70,324	Direct
Feb 24, 2026	VIR Vir Biotechnology, Inc.	Sale(S)	1,430	$9.53	$13,632	Direct
Feb 23, 2026	VIR Vir Biotechnology, Inc.	Sale(S)	1,829	$7.45	$13,631	Direct
Feb 22, 2026	VIR Vir Biotechnology, Inc.	Award(A)	25,000	-	$0	Direct
Feb 13, 2026	VIR Vir Biotechnology, Inc.	Sale(S)	1,530	$7.79	$11,919	Direct
Feb 24, 2025	VIR Vir Biotechnology, Inc.	Sale(S)	1,562	$9.45	$14,766	Direct
Feb 22, 2025	VIR Vir Biotechnology, Inc.	Award(A)	20,000	-	-	Direct
Feb 13, 2025	VIR Vir Biotechnology, Inc.	Sale(S)	1,562	$9.15	$14,291	Direct

1-9 of 9 transactions

About Sabatini Brent

Sabatini Brent (SEC CIK 0002037272) files insider reports with the SEC as SVP, Chief Accounting Officer of Vir Biotechnology, Inc. (VIR).

Signal8 holds 8 ownership filings by Sabatini Brent (1 Form 3, 7 Form 4), filed between Oct 2, 2024 and Jun 2, 2026. Those filings report 9 transactions, from Feb 13, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sabatini Brent's filings is in SAN FRANCISCO, CA.

Recent filings by Sabatini Brent

Jun 1, 2026: Open-market sale of VIR shares (Form 4, code S).
Mar 23, 2026: Open-market sale of VIR shares (Form 4, code S).
Feb 24, 2026: Open-market sale of VIR shares (Form 4, code S).
Feb 23, 2026: Open-market sale of VIR shares (Form 4, code S).
Feb 22, 2026: Grant or award of VIR shares (Form 4, code A).

Other insiders filing for Vir Biotechnology, Inc. (VIR)

Topalian Suzanne Louise, Director
Sawaf Aziz, EVP, Chief Financial Officer
MORE ROBERT J, Director
Coughlin Timothy, Director
Napolitano Janet, Director
Sigal Charles Elliott, Director

How to read Form 4 transaction codes